Saturday, March 6, 2021

China’s Sinopharm says vaccine ‘79% effective’

This puts it behind rival jabs developed by Pfizer and Moderna.

Other News

Kerajaan kaji langkah lindungi sektor komoditi hadapi cuaca panas

Pekebun kecil getah dan kelapa sawit sering terjejas ketika menghadapi musim panas.

205 warga asing ditahan imigresen di pangsapuri Pudu

Kesemua yang ditahan kemudiannya dibawa ke JIM di Kompleks Kementerian Dalam Negeri.

BN’s ‘chief media officer’ suspended, but does the post exist?

Barisan Nasional is said to be in damage control mode after the release of a statement nearly identical to another issued by Pakatan Harapan leader Anwar Ibrahim.

Ketua pegawai media BN digantung, tetapi apakah jawatan itu wujud?

Jawatan itu diwujudkan bagi melindungi presiden Umno yang menerima kritikan parti komponen BN.

Long-distance relationships in the age of the pandemic

A year since Covid-19 emerged as a global pandemic, binational couples kept apart by travel restrictions and border closures continue to hope for a reunion.

Phase 3 trials of a Sinopharm coronavirus vaccine found it was 79% effective, the Chinese pharma giant said Wednesday, lower than rival jabs developed by Pfizer-BioNTech and Moderna but a potential breakthrough in the battle to stem the pandemic in Asia.

China has been racing against the West to develop its own Covid-19 vaccines, with five already in large-scale Phase 3 clinical trials.

But Wednesday’s announced was the first data released regarding the efficacy of a Chinese vaccine candidate.

“The protective effect of the (Sinopharm CNBG Beijing) vaccine against Covid-19 is 79.34%,” said the Beijing Institute of Biological Products, a Sinopharm subsidiary.

Sinopharm has applied to China’s drug regulator for approval of the inactivated coronavirus vaccine, the statement said, a type of inoculation using particles of the pathogen.

But China has struggled to gain international trust for its vaccine candidates, hindered by a lack of transparency on test results.

It has also been slow to complete Phase 3 trials, which had to be conducted abroad due to China’s success at curbing the spread of Covid-19 within its own borders.

Chinese officials have repeatedly assured the public of the vaccines’ safety, claiming that there have been no serious adverse reactions.

More than one million people have already been vaccinated with unapproved vaccines in China under its emergency use programme, including frontline health workers, state-owned enterprise employees and workers planning to travel abroad.

The United Arab Emirates approved a Sinopharm vaccine earlier this month, becoming the first foreign country to approve a China-developed Covid-19 vaccine. It said the vaccine was 86% effective, according to interim results of a Phase 3 trial.

Beijing has pledged to share the vaccine at a fair cost – a potential boost for poorer Asian countries who are otherwise reliant on limited distribution offered by the Covax scheme.

“China has made the firm commitment that after China’s new coronavirus vaccines are completed and put into use, they will serve as a global public product and be supplied to the world at a fair and reasonable price,” foreign ministry spokesman Zhao Lijian said Friday.

“We will also give priority to developing countries for vaccines. This will be made through a variety of ways, including through donations and aid.”

Follow us on Telegram for the latest updates: https://t.me/malaysianow

Subscribe to our newsletter

To be updated with all the latest news and analyses.

Related Articles

New cases continue to hover above 2,000

2,154 new cases, 3,275 recoveries.

Website registration for Covid-19 vaccine now open

This is the first time online registration for the jabs is open outside the MySejahtera app.

Fake news, Shopee says on alleged sale of vaccine

The online shopping platform says no such listings have been found.

2 cases of Nigerian Covid variant found in Malaysia

Health DG Dr Noor Hisham Abdullah says the Nigerian variant may cause an increase in transmissibility and a possible reduction in immune response.

Daily US Covid cases below 40,000 for first time in months

This number peaked at nearly 300,000 new cases on Jan 8 in the country hardest hit by the pandemic, with more than half a million fatalities.